Stimulation of intercellular communication of poor-communicating cells by gap-junction-competent cells enhances the HSV-TK/GCV bystander effect in vitro.
We have previously shown that gap-junctional intercellular communication (GJIC) appears to play a role in the bystander effect that is observed in anticancer suicide gene therapy mediated by herpes simplex virus (HSV) thymidine kinase (tk) and ganciclovir (GCV). We now report that when connexin-expressing (Cx+) cells are present within a noncommunicating population of cells (Cx-), there is GJIC between the Cx+ and Cx- cells and that due to this stimulation of GJIC, the bystander effect also occurs when the 2 cell types are mixed. We transfected HeLa cells, which do not express any detectable level of connexin, with Cx43. The Cx+ and Cx- HeLa cells were further transfected with the tk gene, giving 4 phenotypes: Cx+tk-, Cx+tk+, Cx-tk+ and Cx-tk-. We observed GJIC between Cx+ and Cx- cells, but not between Cx- and Cx- cells, regardless of the tk genotype. Similarly, we observed the HSV-tk/GCV bystander effect in Cx+tk-/Cx-tk+ and Cx+tk+/Cx-tk- cocultures. The extent of the bystander effect in cocultures of Cx+tk- and Cx-tk+ cells was stronger than in cocultures of Cx+tk+ and Cx-tk- cells when each mixture had the same ratio of Cx+ and tk+ cells. These results suggest that Cx-expressing HeLa cells stimulate GJIC capacity between them and non-Cx-expressing HeLa cells, which mediates the bystander effect in mixtures of Cx+ cells and Cx- cells in vitro. Thus, Cx expression even in only a limited fraction of tumor cells may enhance the efficacy of the HSV-tk/GCV strategy by inducing a bystander effect.
Tanaka
T
T
Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, Lyon, France.
Yamasaki
H
H
Mesnil
M
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D001710:Biotin / Q000031:analogs & derivatives* / Q000494:pharmacology; D002450:Cell Communication; D018920:Coculture Techniques; D018031:Connexin 43 / Q000378:metabolism; D017630:Connexins / Q000096:biosynthesis*; D005456:Fluorescent Dyes / Q000494:pharmacology; D015774:Ganciclovir / Q000627:therapeutic use*; D005838:Genotype; D006367:HeLa Cells; D006801:Humans; D008856:Microscopy, Fluorescence; D010641:Phenotype; D010766:Phosphorylation; D018139:Simplexvirus / Q000235:genetics*; D013937:Thymidine Kinase / Q000235:genetics*; D013997:Time Factors; D014162:Transfection
D000998:Antiviral Agents; D018031:Connexin 43; D017630:Connexins; D005456:Fluorescent Dyes; C070614:neurobiotin; D001710:Biotin; D013937:Thymidine Kinase; D015774:Ganciclovir